CNS pipeline · person
Joseph R. Moskal, Ph.D.
Co-Chair of Syndeio Biosciences' Scientific Advisory Board. Professor of Biomedical Engineering at Northwestern University and Director of the Falk Center for Molecular Therapeutics; founder and former CSO of Naurex (acquired by Allergan) and former CSO of Aptinyx. Recognized for NMDA receptor research.
- 1 company
Courtesy Syndeio Biosciences
Current roles
- Syndeio Biosciences, Inc.Co-Chair, Scientific Advisory Board · Advisor
Appears with
People sharing a company with Joseph.
- Anantha Shekhar · Syndeio Biosciences, Inc.
- Derek Small · Syndeio Biosciences, Inc.
- Jacob Vogelstein · Syndeio Biosciences, Inc.
- John Donello · Syndeio Biosciences, Inc.
- Mark DiPaolo · Syndeio Biosciences, Inc.
- Michael G. McCully · Syndeio Biosciences, Inc.
- Pavel Raifeld · Syndeio Biosciences, Inc.
- Robert Berman · Syndeio Biosciences, Inc.
- Steve Brannan · Syndeio Biosciences, Inc.
- Thomas C. Sudhof · Syndeio Biosciences, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.